BFGP-385

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameBFGP-385
Drug Alias NameGP-385BF/GP-385BF-385
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsPeripheral Vascular DiseasesHypertensionThrombosis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesScherer Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScherer HealthcareOno Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular DiseasesHypertensionThrombosis +[5] 

Other Information

ATC CodeN/A
Related LinksN/A